glp 16&1 GLP-1 drugs have taken the world by storm, helping many people lose 11%–16% of their body weight. But a new Cochrane review reveals something surprising: the evidence supporting these blockbuster injections isn't GLP-1 Medications: Everything You Need

For state Medicaid agencies that opt to participate in the model, implementation will be on a rolling basis from May 1, 2026 through January 1, 2027

Patients starting semaglutide or other GLP-1 receptor agonists sometimes notice they feel colder than usual, especially in the first few weeks of treatment

In January, Novo Nordisk started selling a pill form of Wegovy, its previously injection-only weight loss medication

Tirzepatide achieves reductions of up to 2.0 to 2.3 percentage points, which is among the largest A1c improvements seen with any diabetes medication

What Is GLP-1, and How Do These Drugs Work

What do GLP-1 agonists do physiologically, and how should patients understand their mechanism of action